Page last updated: 2024-11-02

pilsicainide and Influenza, Human

pilsicainide has been researched along with Influenza, Human in 2 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitahara, K1
Nakamura, Y1
Tsuneoka, Y1
Adachi-Akahane, S1
Tanaka, H1
Yamazaki, H1
Takahara, A2
Yamazaki, J1
Ikeda, T1
Sugiyama, A2
Suzuki, S1
Hagiwara, M1
Nozaki, S1

Other Studies

2 other studies available for pilsicainide and Influenza, Human

ArticleYear
Cardiohemodynamic and electrophysiological effects of anti-influenza drug oseltamivir in vivo and in vitro.
    Cardiovascular toxicology, 2013, Volume: 13, Issue:3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antiviral Agents; Arterial Pressure; Cardiac Pac

2013
Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:10

    Topics: Animals; Anti-Arrhythmia Agents; Antiviral Agents; Atrial Fibrillation; Atrial Function; Atrial Func

2013